Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent Drug
WP Thyroid
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
What was recalled
WP Thyroid, Westhroid Pure, Thyroid USP, [liothyronine (T3) 2.25 mcg and levothyroxine (T4) 9.5 mcg], 1/4 Grain (16.25 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-5450-4; b) 60-count bottles, NDC 64727-5450-5; c) 90-count bottles, NDC 64727-5450-6; d) 100-count bottles, NDC 64727-5450-1; and e) 1,000-count bottles, NDC 64727-5450-2; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034.
- Recalling firm
- RLC Labs Inc.
- NDC code
- 64727-5450-4
- Origin
- AZ, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-1606-2020
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Levothyroxine recalls
See all
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent Drug
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent Drug
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent Drug
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent Drug
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.